11 compounds · Show all
These descriptions summarize claimed uses; they do not establish effectiveness or safety.
Semaglutide
→Used for appetite control, weight management, and blood-sugar regulation.
Fat Loss & MetabolicTirzepatide
→Used for appetite control, weight management, and blood-sugar regulation through GIP and GLP-1 signaling.
Fat Loss & MetabolicRetatrutide
→Claimed to reduce appetite and body fat and improve metabolic control through three hormone-receptor pathways.
Fat Loss & MetabolicCagrilintide
→Claimed to increase fullness and reduce food intake through amylin-like signaling.
Fat Loss & MetabolicCagri + Sema
→Combines cagrilintide and semaglutide; claimed to strengthen appetite suppression and weight loss.
Fat Loss & MetabolicTesamorelin
→Used to reduce excess visceral abdominal fat in HIV-associated lipodystrophy; also promoted for body composition.
Fat Loss & MetabolicAOD-9604
→Promoted for fat breakdown and weight management.
Fat Loss & MetabolicHGH Frag 176-191
→Promoted for fat breakdown and body-composition changes.
Fat Loss & MetabolicMOTS-c
→Promoted for insulin sensitivity, metabolic health, and exercise performance.
Fat Loss & MetabolicImmune & Longevity5-Amino-1MQ
→Promoted for fat loss and metabolic support through NNMT inhibition; a small molecule, not a peptide.
Fat Loss & MetabolicSLU-PP-332
→Promoted as an exercise-mimetic compound for energy expenditure and endurance; a small molecule, not a peptide.
Fat Loss & Metabolic